Labshake search
Citations for BioLegend :
1 - 50 of 2875 citations for Recombinant Human CD3E Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... Anti-Human CD3e-AlexaFluor 647 (1:100) (Biolegend: #100209), Anti-Human Scribble (1:100 ...
-
bioRxiv - Cell Biology 2023Quote: ... HeLa cells were treated with TNF-α recombinant human protein (Biolegend) at a concentration of 75 ng/ml for 24 h in combination with cycloheximide (CHX ...
-
bioRxiv - Bioengineering 2024Quote: ... Recombinant human FcγIIa (Biolegend), FcγRIIb (Biolegend) ...
-
bioRxiv - Cancer Biology 2020Quote: ... CD3e BV711 (Biolegend 100241), CD25 BV605 (BioLegend#102036)
-
bioRxiv - Cancer Biology 2020Quote: ... CD3e BV711 (Biolegend#100241), CD25 BV605 (BioLegend#102036) ...
-
bioRxiv - Immunology 2022Quote: ... CD3e (145-2C11, BioLegend), FR4 (12A5 ...
-
bioRxiv - Immunology 2022Quote: ... CD3E-APC (Biolegend, 100311). Oligonucleotide barcodes conjugated to phycoerythrin (PE ...
-
bioRxiv - Cancer Biology 2022Quote: ... CD3e-Alexa488 (100321, Biolegend), CD8-APC/Cy7 (100713 ...
-
bioRxiv - Cell Biology 2024Quote: ... Cd3e(APC, 100311, BioLegend), CD4(FITC ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human CD40L (TNFSF5; BioLegend) was added to the media ...
-
bioRxiv - Immunology 2021Quote: ... CD3e (clone:145-2C11, Biolegend), CD11b (clone:M170 ...
-
bioRxiv - Immunology 2022Quote: ... CD3e (clone 145-2C11, BioLegend), CD4 (clone GK1.5 ...
-
bioRxiv - Cancer Biology 2022Quote: ... CD3e-PE (Biolegend; # 100308, RRID:AB_312673), CD4-APC (Biolegend ...
-
bioRxiv - Immunology 2023Quote: ... PE-labeled CD3e (17A2, BioLegend), APC-labeled CD11b (M1/70 ...
-
bioRxiv - Immunology 2024Quote: ... CD3e-APC (BioLegend, 145-2C11), CD45-APCCy7 (BioLegend ...
-
bioRxiv - Immunology 2024Quote: ... anti-CD3e (145-2C11, Biolegend), anti-CD4 (GK1.5 ...
-
bioRxiv - Immunology 2024Quote: ... anti-CD3e (145-2C11, Biolegend), anti-CD45 (30-F11 ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human IL-12p70 and recombinant human IL-18 at 10ng/ml (Biolegend; San Diego, CA).
-
bioRxiv - Bioengineering 2020Quote: ... recombinant human IL-15 (570308, Biolegend), recombinant mouse scIL-12 (130-096 ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human TPO (763706; Biolegend) for HSC culture conditions and 10 ng/mL of SCF ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human IL-15 (570308, Biolegend), recombinant mouse scIL-12 (130-096 ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human interferon gamma (IFNγ; Biolegend) and recombinant human transforming growth factor beta-1 (TGF-β1 ...
-
bioRxiv - Microbiology 2022Quote: ... CD3e (clone 145-2C11, FITC, Biolegend), CD4 (clone RM4-5 ...
-
bioRxiv - Cancer Biology 2021Quote: ... CD3e PE-Dazzle594 (145-2C11; BioLegend), CD3e PE (145-2C11 ...
-
bioRxiv - Immunology 2020Quote: ... CD3e-FITC (Biolegend, clone 145-2C11), NK1.1-APC-Cy7 (Biolegend ...
-
bioRxiv - Immunology 2021Quote: ... CD3e-APC-Cy7 (BioLegend, Cat. #100329), EpCAM-APC-Cy7 (BioLegend ...
-
bioRxiv - Immunology 2022Quote: ... CD3e (145-2C11, BioLegend, catalog # 100306) CD69 (clone H1.2F3 ...
-
bioRxiv - Immunology 2023Quote: ... Biotin-labeled CD3e (145-2C11, BioLegend), Biotin-labeled CD11b (M1/70 ...
-
bioRxiv - Immunology 2023Quote: ... PE-conjugated anti-mouse CD3e (BioLegend), FITC-conjugated anti-mouse CD4 (BioLegend) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 15ng/mL recombinant human TNF (BioLegend #570104) and 1μM Caspase-8 Inhibitor Z-IETD-FMK (R&D Systems #FMK007 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human recombinant TNF was purchased from BioLegend Inc (San Diego ...
-
bioRxiv - Bioengineering 2022Quote: ... 100 IU/mL recombinant human IL-2 (Proleukin, Prometheus Laboratories) and 5 ng/mL recombinant human IL-7 (BioLegend) at 37C ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-CD3e and anti-CD45R/B220 (BioLegend), anti-streptavidin (APC-Cy7 ...
-
bioRxiv - Cancer Biology 2022Quote: ... PE-Cy7 anti-mouse CD3e (BioLegend,100319) and immune cell marker BV785 CD45.1 (BioLegend,110743) ...
-
bioRxiv - Immunology 2019Quote: ... anti-CD3e-FITC (BioLegend, clone 145-2C11), anti-CD62L-PE-dazzle (BioLegend ...
-
bioRxiv - Immunology 2023Quote: ... CD3e-BV-510 (BioLegend, clone UCHT-1) and CD26-PE-CF594 (BD clone M-A251) ...
-
bioRxiv - Cell Biology 2023Quote: ... PerCP-Cy5.5 CD3e (BioLegend clone 145-2C11), APC-Cy7 CD11b (BioLegend clone M1/70) ...
-
bioRxiv - Immunology 2023Quote: ... CD3e-PE/Dazzle594 (Biolegend, clone 145-2C11), CD8-FITC (BD ...
-
bioRxiv - Immunology 2023Quote: ... PE-Cy7-conjugated CD3e (145-2C11) (BioLegend), BUV395-conjugated anti-CD4 (GK1.5 ...
-
bioRxiv - Immunology 2022Quote: ... PBMC derived T cells were stimulated for five days at 37°C with 1μg/mL anti-CD3 and anti-CD28 and 10ng/mL of recombinant human IL-2 and recombinant human IL-12p70 (BioLegend). On day four of stimulation ...
-
bioRxiv - Cell Biology 2022Quote: ... recombinant proteins Serpin E2 (BioLegend, 769002) and Serpin A3 (R&D systems ...
-
bioRxiv - Immunology 2021Quote: ... and 5ng/ml recombinant human G-CSF (BioLegend). The cells were then incubated for 16 hours at 37°C and 5%CO2 ...
-
bioRxiv - Immunology 2020Quote: ... Human recombinant IFN-α2 was from Biolegend (592704) and hybrid IFNα-B/D was from Novartis (CGP35269).
-
bioRxiv - Developmental Biology 2020Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-basic (FGF-2 ...
-
bioRxiv - Biophysics 2023Quote: ... and 2 μg/mL recombinant human CCL2 (Biolegend).
-
bioRxiv - Bioengineering 2023Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-2 (Peprotech) ...
-
bioRxiv - Cell Biology 2023Quote: ... 100 ng/ml recombinant human IGF-1 (BioLegend), 50 ng/ml recombinant human FGF-2 (Peprotech) ...
-
bioRxiv - Immunology 2024Quote: ... plus 20 ng/mL recombinant human BAFF (Biolegend) for 3 days ...
-
bioRxiv - Immunology 2023Quote: ... Skin immune cells were subsequently added to each fibroblasts-placed well and co-cultured in the presence of 20 ng/ml human IL-2 recombinant and 20 ng/ml human IL-15 recombinant (BioLegend, 570304) in 24 well plates (Ratio of 50:1 immune cell-to-fibroblast) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the cells were stained with CD3e (BioLegend, 100319), CD8a (BioLegend ...